Caitong International Asset Management Co. Ltd Takes Position in Omega Healthcare Investors, Inc. $OHI

Caitong International Asset Management Co. Ltd purchased a new stake in Omega Healthcare Investors, Inc. (NYSE:OHI) in the 2nd quarter, HoldingsChannel.com reports. The institutional investor purchased 697 shares of the real estate investment trust’s stock, valued at approximately $26,000.

Several other hedge funds have also made changes to their positions in the company. Vanguard Group Inc. grew its stake in shares of Omega Healthcare Investors by 3.9% in the 1st quarter. Vanguard Group Inc. now owns 39,554,886 shares of the real estate investment trust’s stock valued at $1,506,250,000 after buying an additional 1,492,904 shares during the period. Charles Schwab Investment Management Inc. grew its stake in shares of Omega Healthcare Investors by 2.9% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 4,100,891 shares of the real estate investment trust’s stock valued at $156,162,000 after buying an additional 114,665 shares during the period. Dimensional Fund Advisors LP grew its stake in shares of Omega Healthcare Investors by 4.3% in the 1st quarter. Dimensional Fund Advisors LP now owns 4,058,107 shares of the real estate investment trust’s stock valued at $154,533,000 after buying an additional 165,554 shares during the period. Bank of New York Mellon Corp grew its stake in shares of Omega Healthcare Investors by 6.4% in the 1st quarter. Bank of New York Mellon Corp now owns 3,123,152 shares of the real estate investment trust’s stock valued at $118,930,000 after buying an additional 188,481 shares during the period. Finally, AQR Capital Management LLC grew its stake in shares of Omega Healthcare Investors by 430.8% in the 1st quarter. AQR Capital Management LLC now owns 2,862,117 shares of the real estate investment trust’s stock valued at $108,989,000 after buying an additional 2,322,878 shares during the period. Hedge funds and other institutional investors own 65.25% of the company’s stock.

Insider Buying and Selling at Omega Healthcare Investors

In other news, Director Lisa Egbuonu-Davis sold 2,500 shares of the firm’s stock in a transaction on Friday, August 8th. The shares were sold at an average price of $40.16, for a total value of $100,400.00. Following the sale, the director directly owned 18,654 shares in the company, valued at approximately $749,144.64. This trade represents a 11.82% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.50% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on OHI. Raymond James Financial reaffirmed an “outperform” rating on shares of Omega Healthcare Investors in a research report on Tuesday, September 2nd. Mizuho increased their price objective on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the stock a “neutral” rating in a research report on Thursday, September 11th. Scotiabank increased their price objective on shares of Omega Healthcare Investors from $39.00 to $42.00 and gave the stock a “sector perform” rating in a research report on Thursday, August 28th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Omega Healthcare Investors in a research report on Wednesday, October 8th. Finally, Wells Fargo & Company increased their price objective on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 21st. Six research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, Omega Healthcare Investors currently has a consensus rating of “Moderate Buy” and a consensus price target of $44.50.

Omega Healthcare Investors Stock Performance

Shares of OHI stock opened at $40.91 on Tuesday. The company has a quick ratio of 7.10, a current ratio of 7.10 and a debt-to-equity ratio of 0.96. Omega Healthcare Investors, Inc. has a 52 week low of $35.04 and a 52 week high of $44.42. The stock has a market capitalization of $12.07 billion, a PE ratio of 25.25, a P/E/G ratio of 1.89 and a beta of 0.70. The firm has a 50 day moving average of $41.59 and a two-hundred day moving average of $39.05.

Omega Healthcare Investors (NYSE:OHI) last issued its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 EPS for the quarter, beating the consensus estimate of $0.45 by $0.32. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The company had revenue of $235.60 million during the quarter, compared to analysts’ expectations of $248.49 million. During the same quarter last year, the company posted $0.71 EPS. The firm’s revenue was up 11.8% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. On average, research analysts predict that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 17th. Stockholders of record on Monday, November 3rd will be issued a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.6%. The ex-dividend date is Monday, November 3rd. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 165.43%.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.